Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis. (Q44124868)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Maria Giovanna Danieli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Carla Palmieri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Maria Cristina Refe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Anna Stella Strusi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Giovanni Danieli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Apheresis

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

72-77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

12 November 2019

cites work

1 reference

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

21 January 2018

1 reference

Treatment of lupus nephritis: a meta-analysis of clinical trials

21 January 2018

1 reference

Apheresis for lupus erythematosus: state of the art.

21 January 2018

1 reference

Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

21 January 2018

1 reference

Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG).

21 January 2018

1 reference

Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis

21 January 2018

1 reference

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

Frequency of immediate adverse effects associated with therapeutic apheresis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCA.10020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12210709%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference